Skip to content

Effectiveness of Physiotherapy for Osteoporotic Spinal Fracture

Effectiveness of Physiotherapy for Vertebral Osteoporotic Fracture: a Randomised Controlled Pilot Trial

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00638768
Enrollment
20
Registered
2008-03-19
Start date
2006-02-01
Completion date
2010-02-10
Last updated
2025-07-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoporosis, Vertebral Fracture

Keywords

physical therapy, rehabilitation, pain, osteoporosis, vertebral fracture

Brief summary

The aim of this pilot study was to determine the effect of physiotherapy on impairments and health-related quality of life in people with a painful osteoporotic spinal fracture. It is hypothesised that physiotherapy will reduce impairments and improve quality of life in this patient group.

Interventions

OTHERPhysiotherapy

10 weekly individual sessions with the therapist each lasting approximately 45 minutes. Techniques included postural taping, massage, mobilisation, exercises. The patients also performed home exercises

Sponsors

ANZ Trustees
CollaboratorUNKNOWN
University of Melbourne
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
50 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* if female, at least five years post-menopause * aged \> 50 years * primary osteoporosis defined as DXA T score \< -2.5 at either the spine or proximal femur with at least one morphometric vertebral crush fracture sustained between 3 months to 2 years previously * back pain/discomfort in thoracic or lumbar region felt at least weekly within the last 6 months * stable dose of medication for treatment of osteoporosis (eg. hormone replacement therapy, bisphosphonates) * community dwelling and able to attend for treatment * English speaking

Exclusion criteria

* secondary causes of bone loss such as osteomalacia, glucocorticoid medication etc. * co-morbidities that would interfere with participation in exercise such as severe heart or pulmonary disease, inflammatory joint disease, severe osteoarthritis, psychiatric condition * acute vertebral fracture in past 3 months * signs and symptoms arising from nerve root compression * back pain radiating into the lower limb * previous participation in a formal pain management program for back pain * physiotherapy for back pain in the past 6 months * allergic reaction to adhesive tape or poor skin condition that would prevent use of tape

Design outcomes

Primary

MeasureTime frame
Back pain as assessed by a numeric rating scaleBaseline and 10 weeks

Secondary

MeasureTime frame
activity restriction, health-related quality of life and physical activity levels as well as overall perceived rating of change in back pain. Objective measures of thoracic kyphosis, standing balance, back and shoulder muscle enduranceBaseline and 10 weeks

Countries

Australia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 1, 2026